Contact

Merge Healthcare Upgraded To NASDAQ Global Select Market Merge Healthcare Incorporated, a leading health IT solutions provider, announced that it was upgraded by NASDAQ to the NASDAQ Global Select Market.

Merge Healthcare Upgraded To NASDAQ Global Select Market

.

Merge Healthcare Incorporated (NASDAQ: MRGE), a leading health IT solutions provider, today announced that it was upgraded by NASDAQ to the NASDAQ Global Select Market. Introduced in 2006 as the top of three NASDAQ market tiers, the Global Select Market was designed for public companies that meet the highest listing standards in the world, using metrics such as market value, liquidity, and earnings.

“We are very proud to become a member of this top tier market,” said Jeff Surges, Merge CEO. “Our upgrade to the NASDAQ Global Select Market is a validation of the results we have delivered to date and the growth opportunity in front of us. In addition, it recognizes our strict adherence to corporate governance standards.”

According to NASDAQ, this blue chip market drives visibility and recognition of NASDAQ’s world-class listed companies and their commitment to high standards and good governance. Inclusion in the NASDAQ Global Select Market is a mark of achievement, leadership and stature, and sends an important message to investors.

Merge Healthcare Incorporated develops and integrates information technology to create a better electronic healthcare experience. Merge products, ranging from standards-based development toolkits to sophisticated clinical applications, have been used by healthcare providers, vendors and researchers worldwide for over 20 years. Additional information can be found at www.merge.com.

The matters discussed in this news release may include forward-looking statements, which could involve a number of risks and uncertainties. When used in this press release, the words “will”, “believes”, “intends”, “anticipates”, “expects” and similar expressions, are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, such forward-looking statements. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements.

Press Contact:
Brenda Stewart
Director of Marketing Communications
312-540-6622
brenda.stewart@merge.com

 

© 2017 IBM Watson Health. All Rights Reserved. Privacy | Terms | Email Signup | Sitemap